Manual of Lipidology, 2/E for Endocrinologists, Cardiologists and Diabetologists | Evidence-Based Guide to Statins, PCSK9 Inhibitors and Dyslipidemia Management for Indian Patients: 1

Manual of Lipidology, 2/E , edited by Sujoy Ghosh and Banshi Saboo, provides comprehensive coverage of basic lipid metabolism, lipoprotein biology and the genetics of dyslipidemia, along with a detailed discussion of international lipid guidelines and their relevance to Indian patients. It offers practical guidance on statins, nonstatin therapies, PCSK9 inhibitors, triglyceride-lowering agents, HDL-targeted therapies and lipoprotein apheresis. The manual also includes updated discussion on apolipoproteins, lipoprotein(a), HDL and cardiovascular risk, along with dedicated chapters addressing statin intolerance, statin diabetogenicity, diabetic dyslipidemia and MASLD, with special emphasis on lipid management in specific populations including pregnancy. By integrating recent clinical trial evidence, evolving therapeutic strategies and guideline-based recommendations, it serves as a reliable companion for clinicians involved in cardiovascular risk reduction. Who This Book Is For: Endocrinologists and Diabetologists: practical, guideline-based guidance on managing dyslipidemia alongside diabetes and MASLD. Cardiologists: an evidence-based reference for lipid-lowering therapy and lipoprotein-based cardiovascular risk reduction. Why This Book Helps: Bridges global guidelines and Indian practice: discusses international lipid guidelines specifically for their relevance to Indian patients. Covers the full therapeutic toolkit: statins, nonstatin therapies, PCSK9 inhibitors, triglyceride-lowering agents, HDL-targeted therapies and lipoprotein apheresis in one place. Addresses real prescribing challenges: dedicated chapters on statin intolerance and statin diabetogenicity guide difficult clinical decisions. Extends to special populations: lipid management in pregnancy and other special-population contexts is addressed directly. Key Features: Comprehensive coverage of lipid metabolism, lipoprotein biology and genetics of dyslipidemia. International lipid guidelines discussed for their relevance to Indian patients. Practical guidance on statins, PCSK9 inhibitors, triglyceride-lowering agents and lipoprotein apheresis. Updated discussion on apolipoproteins, lipoprotein(a), HDL and cardiovascular risk. Dedicated chapters on statin intolerance, diabetic dyslipidemia and MASLD.

Disclaimer:

• Manual of Lipidology, 2/E for Endocrinologists, Cardiologists and Diabetologists | Evidence-Based Guide to Statins, PCSK9 Inhibitors and Dyslipidemia Management for Indian Patients: 1 book is not for reading online or for free download in PDF or eBook format.
• Table of Contents, Index, Syllabus, summary and image of Manual of Lipidology, 2/E for Endocrinologists, Cardiologists and Diabetologists | Evidence-Based Guide to Statins, PCSK9 Inhibitors and Dyslipidemia Management for Indian Patients: 1 may be of a different edition or of the same title.
• Price can change due to reprinting, price change by publisher or sourcing cost change for imported books.